Table 2.
Association between the activation Notch-1 and late SV40 factor in liver cancer specimens and clinicopathological features
| Patients | n | Notch1 | LSF2 | Notch1 and LSF3 | P value |
| Gender | 0.5621,1.0002, 0.3123 | ||||
| Male | 20 | 16 | 17 | 14 | |
| Female | 5 | 3 | 4 | 2 | |
| Age (yr) | 0.1941, 0.5482, 0.0753 | ||||
| < 50 | 7 | 4 | 5 | 2 | |
| ≥ 50 | 18 | 15 | 16 | 13 | |
| Histological type | 0.0591, 0.0812, 0.3593 | ||||
| HCC | 17 | 15 | 16 | 13 | |
| Bile duct cell carcinoma | 1 | 0 | 0 | ||
| Nodular hepatocellular carcinoma | 6 | 4 | 5 | 4 | |
| Other | 1 | 0 | 0 | ||
| Cellular differentiation | 0.1371, 0.2942, 1.0003 | ||||
| Well/moderately | 18 | 12 | 14 | 11 | |
| Poor/undifferentiated | 7 | 7 | 7 | 5 | |
| Stage | 0.0061, 0.0062, 0.013 | ||||
| I/II | 8 | 3 | 4 | 2 | |
| III/IV | 17 | 16 | 17 | 14 |
1
Notch1 P value;
2
LSF P value;
3
Notch1 and LSF P values; Fisher’s exact test. HCC: Hepatocellular carcinoma; LSF: Late SV40 factor.